Roee Atlas

Prior to the current position as Rambam MedTec CEO, Dr. Atlas led a Pharma Incubator program (The NIBN) at Ben-Gurion University in the Negev. The incubator activities focused on pre-clinical development of pharmaceutical and biopharmaceutical drug entities, for indications such as cancer, autoimmunity, neurodegeneration, metabolism, and more. At this position Dr. Atlas gained experience in moving forward pre-clinical development programs for small molecules and biopharmaceuticals for various indications. In addition, Dr. Atlas led the Intellectual Property and business aspects of the Incubator. Prior to that Dr. Atlas served as CEO of a biotech startup company centered on pain management in dentistry application. Before that Dr. Atlas was a project manager at Omrix Biopharmaceuticals (a J&J company), in charge of pre-clinical development of tissue regeneration applications for Omrix's Fibrin technology.
Dr. Atlas studied molecular biology and completed a Ph.D. degree at Weizmann Institute in 2005, followed by a postdoc at Columbia Medical school, New York.